Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $0.08 and traded as high as $0.0863. Sernova Biotherapeutics shares last traded at $0.0863, with a volume of 185,000 shares traded.
Sernova Biotherapeutics Trading Up 16.6%
The stock’s 50 day moving average price is $0.08 and its two-hundred day moving average price is $0.10. The firm has a market capitalization of $32.59 million, a price-to-earnings ratio of -2.16 and a beta of 0.90.
Sernova Biotherapeutics (OTCMKTS:SEOVF – Get Free Report) last announced its quarterly earnings data on Thursday, September 10th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01).
Sernova Biotherapeutics Company Profile
Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies intended to treat chronic diseases by replacing or supplementing missing or dysfunctional cells. The company’s primary platform is the Cell Pouch System, an implantable device designed to create a vascularized environment that can house therapeutic cells and release biologically active substances into the body.
Sernova has focused its research and development activities on cell-based treatments for conditions including insulin-dependent diabetes, hemophilia A and hypothyroidism.
Featured Articles
- Five stocks we like better than Sernova Biotherapeutics
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Sernova Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
